Biopreservation Market By Type (Media (Sera), and Equipment (Thawing Equipment, Alarms, Freezers)), By Biospecimen (Human Tissue, Stem Cells, and Organs), By Application (Therapeutic, Research, Clinical Trials, and Other Applications), By Region – Market Trends, Analysis, and Forecast Till 2030

Report Code: PMI447620 | Publish Date: March 2024 | No. of Pages: 170

Global Biopreservation Market Companies

  • BioCision LLC
  • Thermo Fisher Scientic, Inc.
  • BioLife Solutions Inc.
  • Cesca Therapeutics Inc.
  • Core Dynamics Ltd
  • Custom Biogenic Systems Inc.
  • Lifeline Scientific Inc.
  • Merck KGaA
  • Princeton CryoTech Inc.
  • VWR International.

Recent News:

  • In May 2022, X-Therma Inc. acquired Breakthrough Device repute from the FDA for its XT-ViVo Preservation Solution and TimeSeal Organ Transport Device. The TimeSeal Organ Transport Device is supposed to keep grownup donor kidneys at a static hypothermic temperature for the duration of delivery and next transplantation right into a recipient. It makes use of XT-ViVo, a modern-day organ upkeep solution, that's indicated for perfusing and flushing a donor`s kidney both simply earlier than or proper away after elimination from the donor.
  • In February 2022, Guy's and St Thomas', United Kingdom, released a fertility upkeep provider for ovarian tissue cryopreservation for ladies present process most cancers treatment. Growing technological improvements and launches in bio preservation, in conjunction with the cost-effectiveness of those instruments, are predicted to create profitable possibilities for the goal marketplace boom with inside the given timeframe.
  • In December 2021, X-Therma Inc., a biotechnology startup growing generation for regenerative remedy and organ upkeep, closed an oversubscribed USD thirteen million Series A investment round. The financing become being dealt with via way of means of the entrepreneur-run funding employer LOREA AG, with participation from top notch go back angel buyers in addition to Zen11 Holdings, Graphene Ventures, VU Venture Partners, Methuselah Foundation, and some others.
  • In September 2021, the Regenerative Medicine Catalyst Project become released in collaboration with seven companions to screen regenerative remedy studies improvement and investment within USA over the subsequent 3 years. The elevated call for regenerative remedy that employs bio preservation to deal with life-threatening illnesses like most cancers